N@N

Carter Gould Maintained (BIIB) at Hold with Decreased Target to $190 on, Aug 2nd, 2024

^{Published on 2024-10-28 13:08:56 - WOPRAI, Carter Gould}
 

Carter Gould of Barclays, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $200 to $190 on, Aug 2nd, 2024.

Carter has made no other calls on BIIB in the last 4 months.

There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 3 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $214 on, Wednesday, April 17th, 2024
• Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $260 on, Friday, April 12th, 2024
• Chris Schott of "JP Morgan" Maintained at Hold with Decreased Target to $240 on, Thursday, April 11th, 2024

These are the ratings of the 7 analyists that currently disagree with Carter

---

• Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $288 on, Thursday, August 1st, 2024
• Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $294 on, Monday, July 29th, 2024
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
• Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
• Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy and Held Target at $340 on, Thursday, May 16th, 2024
• Morten Herholdt of "HSBC" Maintained at Strong Buy with Increased Target to $342 on, Friday, May 3rd, 2024
• Jay Olson of "Oppenheimer" Maintained at Buy and Held Target at $270 on, Monday, April 29th, 2024

Contributing Sources

---